Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Strumane

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchangeAran F Labrijn, Joyce I Meesters, Bart E C G de Goeij, et al.
Haematologica|February 23, 2019
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clusteringSimone C Oostindie, Hilma J van der Horst, Margaret A Lindorfer, et al.
Science (New York, N.Y.)|March 15, 2014
Complement is activated by IgG hexamers assembled at the cell surfaceChristoph A Diebolder, Frank J Beurskens, Rob N de Jong, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Blood Cancer Journal|April 29, 2020
DuoHexaBody-CD37<sup>®</sup>, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignanciesSimone C Oostindie, Hilma J van der Horst, Laurens P Kil, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchangeAran F Labrijn, Joyce I Meesters, Bart E C G de Goeij, et al.
Haematologica|February 23, 2019
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clusteringSimone C Oostindie, Hilma J van der Horst, Margaret A Lindorfer, et al.
Science (New York, N.Y.)|March 15, 2014
Complement is activated by IgG hexamers assembled at the cell surfaceChristoph A Diebolder, Frank J Beurskens, Rob N de Jong, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Blood Cancer Journal|April 29, 2020
DuoHexaBody-CD37<sup>®</sup>, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignanciesSimone C Oostindie, Hilma J van der Horst, Laurens P Kil, et al.
Pageof 2